Ford, J., Tassorelli, C., Leroux, E., Wang, S., Ayer, D., Nichols, R., & Detke, H. (2020). Changes in patient functioning and disability: Results from a phase 3, double-blind, randomized, placebo-controlled clinical trial evaluating galcanezumab for chronic migraine prevention (REGAIN). Qual Life Res.

Ford, Janet, Cristina Tassorelli, Elizabeth Leroux, Shufang Wang, David Ayer, Russell Nichols, und Holland Detke. "Changes in Patient Functioning and Disability: Results From a Phase 3, Double-blind, Randomized, Placebo-controlled Clinical Trial Evaluating Galcanezumab for Chronic Migraine Prevention (REGAIN)." Qual Life Res 2020.

Ford, Janet, et al. "Changes in Patient Functioning and Disability: Results From a Phase 3, Double-blind, Randomized, Placebo-controlled Clinical Trial Evaluating Galcanezumab for Chronic Migraine Prevention (REGAIN)." Qual Life Res 2020.